Recent studies showed that weight loss could decrease hepatic steatosis and insulin sensitivity [17] and a direct effect of GLP-1 on hepatocytes of human subjects with NASH could be mediated by activating of genes involved in fatty acid oxidation and insulin sensitivity [18]. The gene discussed is GCG; the disease is Hepatic steatosis.